Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    Fibrosing Colonopathy in US Patients with Cystic Fibrosis
Previous Study | Return to List | Next Study

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01652157
Recruitment Status : Terminated (Strategic considerations)
First Posted : July 27, 2012
Last Update Posted : March 22, 2021
Sponsor:
Collaborators:
Cystic Fibrosis Foundation
Digestive Care, Inc.
Nestle Health Science
VIVUS, Inc.
Information provided by (Responsible Party):
AbbVie

Brief Summary:
This is a long-term study in cystic fibrosis patients who are participating in the Cystic Fibrosis Patient Registry to assess the occurrence and risk factors for a rare bowel disorder called fibrosing colonopathy (narrowing of the large intestine). Patients will be followed at their regular clinical care visits over a 10-year period and approached if they develop symptoms of fibrosing colonopathy for collection and use of further detailed information.

Condition or disease Intervention/treatment
Fibrosing Colonopathy Biological: ULTRESA Biological: PANCREAZE Biological: CREON Biological: ZENPEP Biological: other non-sponsor pancreatic enzyme replacement therapy Biological: PERTZYE Other: No pancreatic enzyme replacement therapy

Detailed Description:
This is a prospective, observational, population-based cohort study in US cystic fibrosis patients participating in the Cystic Fibrosis Patient Registry in order to assess the incidence of and risk factors for fibrosing colonopathy. Cystic fibrosis (CF) patients participating in the registry from participating sites, as well as new CF patients enrolled in the registry at these sites over a 2-year period, will serve as the base study population (estimated to include 24,500-25,000 cystic fibrosis patients between the first patient encounter documented in the registry from any participating site and the 31st of July 2014). Cystic fibrosis patients in the base study population will be followed at their regular clinical care visits and, any patients presenting over a 10-year period with signs and symptoms of suspected fibrosing colonopathy, based on a prospective definition, will be approached to obtain a study-specific informed consent for collection of additional data outside the standard registry data collection form in order to augment surveillance. Data routinely collected via the standard CF registry will be used to determine exposure to any specific pancreatic enzyme replacement therapy and to assess potential risk factors for the outcome of confirmed fibrosing colonopathy. An independent adjudication panel will be utilized to validate the diagnosis of fibrosing colonopathy based on a prospective case definition as well as decision rules.

Layout table for study information
Study Type : Observational
Actual Enrollment : 17 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients With Cystic Fibrosis Treated With Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors(The CF-FC Study)
Actual Study Start Date : July 31, 2012
Actual Primary Completion Date : April 8, 2020
Actual Study Completion Date : April 8, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cystic Fibrosis

Group/Cohort Intervention/treatment
Cystic fibrosis (CF) patients in the CF Patient Registry
Patients diagnosed with cystic fibrosis at participating sites who are providing data to the Cystic Fibrosis Patient Registry
Biological: ULTRESA
pancreatic enzyme replacement therapy
Other Name: pancrelipase

Biological: PANCREAZE
pancreatic enzyme replacement therapy
Other Name: pancrelipase

Biological: CREON
pancreatic enzyme replacement therapy
Other Name: pancrelipase

Biological: ZENPEP
pancreatic enzyme replacement therapy
Other Name: pancrelipase

Biological: other non-sponsor pancreatic enzyme replacement therapy
pancreatic enzyme replacement therapy
Other Name: pancrelipase

Biological: PERTZYE
pancreatic enzyme replacement therapy
Other Name: pancrelipase

Other: No pancreatic enzyme replacement therapy
Cystic fibrosis patients in the cystic fibrosis registry not receiving any pancreatic enzyme replacement therapy (approximately 10%)




Primary Outcome Measures :
  1. Incidence rate of fibrosing colonopathy confirmed by an independent adjudication panel in patients receiving ZENPEP [ Time Frame: up to 10 years ]
    Fibrosing colonopathy is confirmed by an independent adjudication panel based on prospectively defined criteria.

  2. Incidence rate of fibrosing colonopathy confirmed by an independent adjudication panel in patients receiving ULTRESA [ Time Frame: up to 10 years ]
    Fibrosing colonopathy is confirmed by an independent adjudication panel based on prospectively defined criteria.

  3. Incidence rate of fibrosing colonopathy confirmed by an independent adjudication panel in patients receiving PERTZYE. [ Time Frame: up to 10 years ]
    Fibrosing colonopathy is confirmed by an independent adjudication panel based on prospectively defined criteria.

  4. Incidence rate of fibrosing colonopathy confirmed by an independent adjudication panel in patients receiving CREON [ Time Frame: up to 10 years ]
    Fibrosing colonopathy is confirmed by an independent adjudication panel based on prospectively defined criteria.

  5. Incidence rate of fibrosing colonopathy confirmed by an independent adjudication panel in patients receiving PANCREAZE [ Time Frame: up to 10 years ]
    Fibrosing colonopathy is confirmed by an independent adjudication panel based on prospectively defined criteria.

  6. Incidence rate of fibrosing colonopathy confirmed by an independent adjudication panel in patients not receiving pancreatic enzyme therapy. [ Time Frame: up to 10 years ]
    Fibrosing colonopathy is confirmed by an independent adjudication panel based on prospectively defined criteria.

  7. Incidence rate of fibrosing colonopathy confirmed by an independent adjudication panel in patients receiving non-sponsor pancreatic enzyme replacement therapy [ Time Frame: up to 10 years ]
    Fibrosing colonopathy is confirmed by an independent adjudication panel based on prospectively defined criteria.


Secondary Outcome Measures :
  1. Odds ratio (95% confidence interval) to quantify the association between possible risk factors and confirmed fibrosing colonopathy [ Time Frame: up to 10 years ]
    Potential risk factors include demographics, medical history, and concurrent medications, including daily dosage and length of specific pancreatic enzyme replacement therapy.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 99 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cystic fibrosis patients who are active in the Cystic Fibrosis Patient Registry
Criteria

Inclusion Criteria:

The inclusion criteria for enrollment in the Base Study Population

  • Diagnosed with cystic fibrosis,
  • Enrolled in the Cystic Fibrosis Patient Registry
  • Receiving medical care at a Cystic Fibrosis Foundation-accredited care center providing data to the Cystic Fibrosis Patient Registry

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01652157


Locations
Hide Hide 123 study locations
Layout table for location information
United States, Alabama
Children's Hospital of Alabama /ID# 78920
Birmingham, Alabama, United States, 35233
United States, Alaska
Alaska Medical Center /ID# 79256
Anchorage, Alaska, United States, 99508
United States, Arizona
Phoenix Children's Hospital /ID# 78906
Phoenix, Arizona, United States, 85016-7710
University of Arizona Cancer Center - North Campus /ID# 78939
Tucson, Arizona, United States, 85719-1478
United States, Arkansas
Arkansas Children's Hospital /ID# 79265
Little Rock, Arkansas, United States, 72202
University of Arkansas for Medical Sciences /ID# 76785
Little Rock, Arkansas, United States, 72205
United States, California
Ucsd /Id# 105039
La Jolla, California, United States, 92093
Loma Linda University /ID# 79237
Loma Linda, California, United States, 92354
Miller Childrens Hospital /ID# 78896
Long Beach, California, United States, 90806
Kaiser Permanente Regional Met /ID# 79235
Los Angeles, California, United States, 90027
Usc /Id# 76793
Los Angeles, California, United States, 90033
Children's Hosp and Res Ctr /ID# 79295
Oakland, California, United States, 94609
Kaiser Permanente /ID# 78899
Oakland, California, United States, 94611
UC Davis Comprehensive Cancer Center - Main /ID# 118935
Sacramento, California, United States, 95817
California Pacific Medical Ctr /ID# 76775
San Francisco, California, United States, 94115
Univ California, San Francisco /ID# 78925
San Francisco, California, United States, 94143-2204
Stanford University /ID# 95156
Stanford, California, United States, 94305
United States, Colorado
Univ of Colorado Cancer Center /ID# 79277
Aurora, Colorado, United States, 80045
National Jewish Health /ID# 76784
Denver, Colorado, United States, 80206
United States, Connecticut
CT Childrens Medical Ctr, US /ID# 78923
Hartford, Connecticut, United States, 06106
Yale University /ID# 78940
New Haven, Connecticut, United States, 06510
United States, Delaware
Nemours/Alfred duPont Hospital for Children /ID# 78945
Wilmington, Delaware, United States, 19803
United States, District of Columbia
Children's National Medical Center /ID# 79373
Washington, District of Columbia, United States, 20010
United States, Florida
Central FL Pulmonary Altamonte /ID# 76776
Altamonte Springs, Florida, United States, 32701
University of Florida - Archer /ID# 76790
Gainesville, Florida, United States, 32610
University of Florida - Archer /ID# 78928
Gainesville, Florida, United States, 32610
Joe DiMaggio Children's Hospital at Memorial /ID# 79234
Hollywood, Florida, United States, 33021-5402
Nemour Child Clin FL, US /ID# 78898
Jacksonville, Florida, United States, 32207
University of Miami, Miller School of Medicine /ID# 78927
Miami, Florida, United States, 33136
Nemours Children's Clinic /ID# 78917
Orlando, Florida, United States, 32801
Arnold Palmer Hosp Children /ID# 96075
Orlando, Florida, United States, 32806
All Children's Hospital /ID# 79264
Saint Petersburg, Florida, United States, 33701
United States, Georgia
Emory University Hospital /ID# 79394
Atlanta, Georgia, United States, 30322
Children's Healthcare of Atlanta - Ferry Rd /ID# 116275
Atlanta, Georgia, United States, 30342-1605
Georgia Regents University /ID# 79395
Augusta, Georgia, United States, 30912
United States, Idaho
St Luke's Cystic Fibrosis Center of Idaho /ID# 79259
Boise, Idaho, United States, 83702
United States, Illinois
Duplicate_Childrens Hospital of Chicago /ID# 79296
Chicago, Illinois, United States, 60611
University of Chicago /ID# 78924
Chicago, Illinois, United States, 60637-1443
Loyola University Medical Ctr /ID# 76780
Maywood, Illinois, United States, 60153
Advocate Lutheran Gen Children /ID# 76781
Park Ridge, Illinois, United States, 60068
OSF Saint Francis Medical Ctr /ID# 78905
Peoria, Illinois, United States, 61603
United States, Indiana
Lutheran Hospital of Indiana /ID# 79238
Fort Wayne, Indiana, United States, 46804
Indiana University /ID# 121395
Indianapolis, Indiana, United States, 46202
Indiana University /ID# 78903
Indianapolis, Indiana, United States, 46202
United States, Iowa
University of Iowa Hospitals and Clinics /ID# 78921
Iowa City, Iowa, United States, 52242
United States, Kansas
University of Kansas Health Sy /ID# 78929
Kansas City, Kansas, United States, 66160-8500
Via Christi Specialty Clinics /ID# 78946
Wichita, Kansas, United States, 67214
United States, Kentucky
Kentucky Clinic /ID# 78922
Lexington, Kentucky, United States, 40506
University of Louisville /ID# 78926
Louisville, Kentucky, United States, 40202
United States, Louisiana
Tulane Univ /ID# 78916
New Orleans, Louisiana, United States, 70112
Louisiana State Univ HSC /ID# 78943
Shreveport, Louisiana, United States, 71130
United States, Maine
MMP Women's Health /ID# 78894
Portland, Maine, United States, 04102
United States, Maryland
Johns Hopkins University /ID# 78893
Baltimore, Maryland, United States, 21287
United States, Massachusetts
Tufts-New England Medical Ctr /ID# 79254
Boston, Massachusetts, United States, 02111
Massachusetts General Hospital /ID# 78895
Boston, Massachusetts, United States, 02114
Boston Childrens Hospital /ID# 79276
Boston, Massachusetts, United States, 02115
Baystate Medical Center /ID# 103437
Springfield, Massachusetts, United States, 01199
UMass Memorial Medical Center /ID# 78954
Worcester, Massachusetts, United States, 01655
United States, Michigan
University of Michigan Hospitals /ID# 99035
Ann Arbor, Michigan, United States, 48109
Children's Hospital of MI /ID# 79278
Detroit, Michigan, United States, 48201
Michigan State University /ID# 78950
East Lansing, Michigan, United States, 48824
Helen DeVos Childrens Hospital /ID# 79397
Grand Rapids, Michigan, United States, 49503
United States, Minnesota
University of Minnesota /ID# 76791
Minneapolis, Minnesota, United States, 55455-0356
United States, Mississippi
Univ of Mississippi Med Ctr,US /ID# 78934
Jackson, Mississippi, United States, 39216-4643
United States, Missouri
University of Missouri /ID# 109755
Columbia, Missouri, United States, 65212
The Children's Mercy Hospital /ID# 78948
Kansas City, Missouri, United States, 64108
Cardinal Glennon Children's Ho /ID# 79275
Saint Louis, Missouri, United States, 63104
Children's Hospital St Louis /ID# 78910
Saint Louis, Missouri, United States, 63110
United States, Nebraska
Univ Nebraska Med Ctr /ID# 78932
Omaha, Nebraska, United States, 68198
United States, New Hampshire
Dartmouth-Hitchcock Medical Center /ID# 78957
Lebanon, New Hampshire, United States, 03756
United States, New Jersey
St. Barnabas Medical Center /ID# 79258
Livingston, New Jersey, United States, 07039
Monmouth Medical Center /ID# 78901
Long Branch, New Jersey, United States, 07740
Goryeb Chidlren's Hospital /ID# 76782
Morristown, New Jersey, United States, 07960
Rutgers Robert Wood Johnson /ID# 119978
New Brunswick, New Jersey, United States, 08901
United States, New York
Albany Medical College /ID# 76774
Albany, New York, United States, 12208
Cystic Fibrosis Therapeutics /ID# 78941
Buffalo, New York, United States, 14222
North Shore University Hospital /ID# 76779
New Hyde Park, New York, United States, 11040
Mount Sinai Beth Israel /ID# 76773
New York, New York, United States, 10003
Columbia Univ Medical Center /ID# 79376
New York, New York, United States, 10032-3725
Univ Rochester Med Ctr /ID# 92713
Rochester, New York, United States, 14642
SUNY Upstate Medical University - Downtown /ID# 78912
Syracuse, New York, United States, 13210
New York Medical College /ID# 78956
Valhalla, New York, United States, 10595
United States, North Carolina
Univ NC Chapel Hill /ID# 78937
Chapel Hill, North Carolina, United States, 27514-4220
Duke University Medical Center /ID# 79393
Durham, North Carolina, United States, 27710-3000
United States, North Dakota
Mid Dakota Clinic, PC /ID# 78958
Bismarck, North Dakota, United States, 58504
United States, Ohio
Akron Childrens Hospital /ID# 79263
Akron, Ohio, United States, 44308
Cincinnati Children's Hospital /ID# 79375
Cincinnati, Ohio, United States, 45229
University of Cincinnati /ID# 76789
Cincinnati, Ohio, United States, 45267-0585
Case Western Reserve Univ /ID# 78904
Cleveland, Ohio, United States, 44106
Nationwide Childrens Hospital /ID# 78897
Columbus, Ohio, United States, 43205
The Childrens Medical Center /ID# 78915
Dayton, Ohio, United States, 45404
ProMedica Toledo Hospital /ID# 78913
Toledo, Ohio, United States, 43606
United States, Oklahoma
Univ Oklahoma HSC /ID# 79279
Oklahoma City, Oklahoma, United States, 73104
United States, Oregon
Kaiser Permanente, NW /ID# 79236
Portland, Oregon, United States, 97227
Oregon Health and Science University /ID# 78900
Portland, Oregon, United States, 97239
United States, Pennsylvania
Geisinger Medical Center /ID# 79233
Danville, Pennsylvania, United States, 17822
Penn State Child Hosp.Hersh,PA /ID# 79398
Hershey, Pennsylvania, United States, 17033
Children's Hosp Philadelphia /ID# 79280
Philadelphia, Pennsylvania, United States, 19104
Drexel Univ College of Med /ID# 76777
Philadelphia, Pennsylvania, United States, 19129
St. Christopher's Hospital /ID# 78908
Philadelphia, Pennsylvania, United States, 19134
Child Hosp of Pittsburgh,PA /ID# 79281
Pittsburgh, Pennsylvania, United States, 15213-2583
United States, Rhode Island
Rhode Island Hospital /ID# 79274
Providence, Rhode Island, United States, 02903
United States, South Carolina
Medical University of South Carolina /ID# 79262
Charleston, South Carolina, United States, 29425
United States, South Dakota
Sanford Research/USD /ID# 78909
Sioux Falls, South Dakota, United States, 57104-8805
United States, Tennessee
LeBonheur Children's Med Ctr /ID# 78938
Memphis, Tennessee, United States, 38103
Vanderbilt Univ Med Ctr /ID# 78947
Nashville, Tennessee, United States, 37232-0011
United States, Texas
Specially for Children /ID# 79213
Austin, Texas, United States, 78723
UT Southwestern Medical Center /ID# 78914
Dallas, Texas, United States, 75390-7208
Cook Children's Med. Center /ID# 78949
Fort Worth, Texas, United States, 76104
Baylor College of Medicine /ID# 79273
Houston, Texas, United States, 77030-3411
Univ Texas HSC San Antonio /ID# 79374
San Antonio, Texas, United States, 78229
The Univ Texas HSC at Tyler /ID# 79261
Tyler, Texas, United States, 75708
United States, Utah
University of Utah /ID# 76794
Salt Lake City, Utah, United States, 84112-5500
United States, Vermont
University of Vermont Medical Center /ID# 78933
Burlington, Vermont, United States, 05401-1473
United States, Virginia
University of Virginia /ID# 78942
Charlottesville, Virginia, United States, 22908
Child Hosp of the King's Dtr's /ID# 79293
Norfolk, Virginia, United States, 23507
Children's Hospital of Richmon /ID# 78955
Richmond, Virginia, United States, 23298
United States, Washington
Seattle Children's Hospital /ID# 78902
Seattle, Washington, United States, 98105
Arthritis Northwest, PLLC /ID# 79257
Spokane, Washington, United States, 99204-2336
United States, West Virginia
West Virginia Univ School Med /ID# 78953
Morgantown, West Virginia, United States, 26506
United States, Wisconsin
Univ of Wisconsin Hosp/Clinics /ID# 78944
Madison, Wisconsin, United States, 53792-0001
Froedtert & the Medical College of Wisconsin /ID# 76778
Milwaukee, Wisconsin, United States, 53226-3522
Children's Hospital Wisconsin - Milwaukee Campus /ID# 79294
Milwaukee, Wisconsin, United States, 53226
Sponsors and Collaborators
AbbVie
Cystic Fibrosis Foundation
Digestive Care, Inc.
Nestle Health Science
VIVUS, Inc.
Investigators
Layout table for investigator information
Study Director: Craig Peterson VIVUS, Inc.
Additional Information:
Layout table for additonal information
Responsible Party: AbbVie
ClinicalTrials.gov Identifier: NCT01652157    
Other Study ID Numbers: CFFC-OB-11
First Posted: July 27, 2012    Key Record Dates
Last Update Posted: March 22, 2021
Last Verified: March 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by AbbVie:
prospective
observational
pancreatic insufficiency
pancreatic enzyme replacement therapy
fibrosing colonopathy
patients with cystic fibrosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Cystic Fibrosis
Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Pancrelipase
Pancreatin
Gastrointestinal Agents